CD4 and myeloid sarcoma: In human MS lesions, it has been demonstrated that mesenchymal perivascular cells, which share common markers with pericytes, express HLA-DR in inflammatory active lesions, at least suggesting that pericytes might be involved in the presentation of antigens towards CD4+ T cells [22].